Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase
- 26 February 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (7) , 1367-1371
- https://doi.org/10.1016/s0960-894x(03)00096-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Phase I Clinical and Pharmacologic Study of Chronic Oral Administration of the Farnesyl Protein Transferase Inhibitor R115777 in Advanced CancerJournal of Clinical Oncology, 2002
- Farnesyltransferase inhibitors: mechanism and applicationsExpert Opinion on Investigational Drugs, 2001
- Current status of clinical trials of farnesyltransferase inhibitorsCurrent Opinion in Oncology, 2001
- Farnesyltransferase inhibitorsSeminars in Oncology, 2001
- Discovery of a Series of Cyclohexylethylamine-Containing Protein Farnesyltransferase Inhibitors Exhibiting Potent Cellular ActivityJournal of Medicinal Chemistry, 1999
- Second-Generation Peptidomimetic Inhibitors of Protein Farnesyltransferase Demonstrating Improved Cellular Potency and Significant in Vivo EfficacyJournal of Medicinal Chemistry, 1999
- Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacementsBioorganic & Medicinal Chemistry Letters, 1999
- Potent and Selective Non-Cysteine-Containing Inhibitors of Protein FarnesyltransferaseJournal of Medicinal Chemistry, 1998
- Design and Synthesis of Non-Peptide Ras CAAX Mimetics as Potent Farnesyltransferase InhibitorsJournal of Medicinal Chemistry, 1996
- ras GENESAnnual Review of Biochemistry, 1987